Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension studyMartin Reck, Stephen V. Liu, Gilberto de Castro et al.|Lung Cancer|2024Cited by 66
Effects of <i>ERBB2</i> amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancerLarry E. Morrison, John S. Coon, Susan Jewell et al.|Genes Chromosomes and Cancer|2007Cited by 26
PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapyMary J. Fidler, Philip Bonomi, Larry E. Morrison et al.|British Journal of Cancer|2011Cited by 20